ICYMI – New Autism & Cord Blood Clinical Trial Results are out.

Results of a Phase I Clinical Safety Trial using a child’s own cord blood were recently published, and are giving families and researchers hope. Read More

Go Blue For Autism

With April being the first full month of spring, we start to say goodbye to the winter weather and hello to the brighter and warmer months.   Along with growth and renewal, April also represents something else – World Autism Month. Read More

Autism and Cord Blood - A Phase II Clinical Research Trial Is Underway

Autism & Cord Blood Stem Cells:
Phase II Research Study Underway

Duke University Medical Center is currently conducting a Phase II clinical research trial using a cord blood infusion for children with Autism Spectrum Disorder (ASD). The goal of the study is to to determine if there is a benefit from an intravenous infusion of autologous (the child’s own) or unrelated donor cord blood to children with ASD.

This clinical trial offers hope for families affected with ASD, and over a dozen ViaCord families have requested access to their banked cord blood in order to participate in the clinical research trial. Read More

Cord Blood Updates:
What You Need To Know

From the number of cord blood transplants to new potential uses for these amazing cells, here are three recent updates worth knowing about!

Read More

Light It Up Blue For #AutismAwareness

Autism, a disorder that appears in the first three years of life, affects the brain’s development and impacts social and communication skills.While the exact causes of Autism Spectrum Disorder (ASD) are unknown, research suggests that both genes and environment play important roles. Read More

Cord Blood & Current Medical Treatments

CB Myth #3

Read More